Pulmobiotics announces award of 1.9m € EIC Transition funding
BARCELONA, Spain – February 28, 2023 – Pulmobiotics SL, a biotechnology company pioneering novel live biotherapeutics (LPBs) for the...
Safety and Efficacy results of engineered PB_VAP strain published today in Nature Biotechnology.
• Safety and Efficacy results of engineered PB_VAP strain published today in Nature Biotechnology. Read our publication • Press release...
Novel genome editing tool published in Nucleic Acid Research by Pulmobiotics SL
Novel genome editing tool published in Nucleic Acid Research by Pulmobiotics SL “SURE editing: combining oligo-recombineering and...
First manuscript of Pulmobiotics:
Bacteria present a promising delivery system for treating human diseases. Here, we engineered the genome-reduced human lung pathogen...
Premio Nacional de Biologia
The 26 th of October 2021, Center for Genomic Regulation (CRG) has received the National Innovation Award for the Creation of a...
Pulmobiotics obtained the price from the Catalan Society of Biology to the Start-up 2021
The 16th of September 2021, we obtained the price from the Catalan Society of Biology to the Start-up 2021